These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8419095)

  • 1. Propylthiouracil hepatotoxicity. A review and case presentation.
    Levy M
    Clin Pediatr (Phila); 1993 Jan; 32(1):25-9. PubMed ID: 8419095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil-induced fulminant hepatitis: case report and review of the literature.
    Deidiker R; deMello DE
    Pediatr Pathol Lab Med; 1996; 16(5):845-52. PubMed ID: 9025882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Asymptomatic hepatitis induced by propylthiouracil].
    De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
    Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis associated with propylthiouracil treatment.
    Garty BZ; Kauli R; Ben-Ari J; Lubin E; Nitzan M; Laron Z
    Drug Intell Clin Pharm; 1985 Oct; 19(10):740-2. PubMed ID: 4053978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
    Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature.
    Jonas MM; Eidson MS
    J Pediatr Gastroenterol Nutr; 1988; 7(5):776-9. PubMed ID: 3054039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylthiouracil and hepatitis: a case report.
    Reddy CM
    J Natl Med Assoc; 1979 Dec; 71(12):1185-6. PubMed ID: 522183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propylthiouracil-induced hepatic damage.
    Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
    Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracil-induced hepatic failure and encephalopathy in a child.
    Kirkland JL
    DICP; 1990 May; 24(5):470-1. PubMed ID: 2343593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
    Parolin MB; Lopes RW; Telles JE; Ioshii SO; Hajar N
    Arq Gastroenterol; 2000; 37(2):129-32. PubMed ID: 11144016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
    Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
    J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant hepatic failure associated with propylthiouracil.
    Ruiz JK; Rossi GV; Vallejos HA; Brenet RW; Lopez IB; Escribano AA
    Ann Pharmacother; 2003 Feb; 37(2):224-8. PubMed ID: 12549953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hepatotoxicity on beginning propylthiouracil therapy.
    Lock DR; Sthoeger ZM
    J Clin Gastroenterol; 1997 Jun; 24(4):267-9. PubMed ID: 9252857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The propylthiouracil dilemma.
    Glinoer D; Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing vasculitis in a patient affected by autoimmune hyperthyroidism treated with propylthiouracil.
    Antonucci A; Bardazzi F; Iozzo I; Patrizi A
    Dermatol Ther; 2010; 23 Suppl 2():S41-3. PubMed ID: 20482568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.